Literature DB >> 216320

[Tumour regression in pituitary adenoma by bromocriptin (author's transl)].

D Mühlenstedt, F Osmers, H P Schneider.   

Abstract

A 35 year old patient with longstanding amenorrhea-galactorrhea due to a pituitary macroadenoma has been observed for a period of more than 2 years. During this time tumour expansion was radiologically evident. A full term pregnancy was responsible for most of the tumour growth. Following postpartum period Bromocriptin treatment led to considerable regression of the adenoma. Recalcification of sella structures and an involuted sella volume was radiologically evident. With reference to the experimental investigations of Lloyd (1975) and following the suggestions of L'Hermite (1977) and Vaidya (1977) this tumour regression is interpreted as being due to the antimitotic effect of Bromocriptin via inhibition of c-AMP and DNA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216320     DOI: 10.1007/bf02119225

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  5 in total

1.  [Chronic recurrent mastitis associated with galactorrhea: case report (author's transl)].

Authors:  D Mühlenstedt; H P Schneider
Journal:  Geburtshilfe Frauenheilkd       Date:  1976-12       Impact factor: 2.915

2.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

3.  [Pituitary adenoma with lactotropic cells and adenoma with galactorrhea].

Authors:  M Linquette; P Fossati; J Lefebvre; G Derrien; J Buvat; E Laine
Journal:  Rev Fr Endocrinol Clin       Date:  1972 Jan-Feb

4.  Prolactin oversuppression.

Authors:  H G Bohnet; D Mühlenstedt; J P Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1977-10-28

5.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

  5 in total
  3 in total

1.  The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.

Authors:  R C Williams; C Sherman; M T Buckman
Journal:  West J Med       Date:  1983-03

2.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

Review 3.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.